GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Research & Development

J.Molner AS (OTSE:MOLNR) Research & Development : €0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. J.Molner AS's Research & Development for the six months ended in Dec. 2023 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.


J.Molner AS Research & Development Historical Data

The historical data trend for J.Molner AS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Research & Development Chart

J.Molner AS Annual Data
Trend Dec21 Dec22 Dec23
Research & Development
- - -

J.Molner AS Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development - - - - -

J.Molner AS Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


J.Molner AS  (OTSE:MOLNR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


J.Molner AS Research & Development Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


J.Molner AS (OTSE:MOLNR) Business Description

Traded in Other Exchanges
N/A
Address
Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618
J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines